FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant NGS Genetic DNA Test
Introduction
The FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant NGS Genetic DNA Test is a vital diagnostic tool designed to identify genetic mutations associated with Spinocerebellar Ataxia Type 27 (SCA27), a neurological disorder. This test utilizes Next Generation Sequencing (NGS) technology, allowing for precise detection of mutations in the FGF14 gene, which plays a critical role in neuronal function.
What the Test Measures
This test specifically detects mutations in the FGF14 gene, which may lead to the development of SCA27. By analyzing the genetic material, healthcare providers can assess the risk of developing this condition, enabling proactive management and treatment strategies.
Who Should Consider This Test
Individuals with a family history of neurological disorders, particularly those exhibiting symptoms such as:
- Uncoordinated movements
- Difficulty with balance
- Speech difficulties
- Muscle weakness
Additionally, those with known genetic predispositions to SCA27 should consider this test for early diagnosis and intervention.
Benefits of Taking the Test
- Early detection of genetic mutations associated with SCA27.
- Informed decision-making regarding health management and lifestyle choices.
- Access to genetic counseling, helping to understand family planning and risk assessment.
- Empowerment through knowledge of one’s genetic health.
Understanding Your Results
Results from the FGF14 Gene Spinocerebellar Ataxia Type 27 test will indicate whether a mutation is present. A positive result signifies an increased risk of developing SCA27, while a negative result suggests no identified mutation. It is essential to discuss these results with a healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant NGS Genetic DNA Test | 400,000 | 560,000 |
Booking the Test
To book the FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any additional information you may need.
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical history of the patient is required along with a genetic counseling session to draw a pedigree chart of family members affected with FGF14 Gene Spinocerebellar Ataxia Type 27.
Take control of your health today by understanding your genetic risks with the FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant NGS Genetic DNA Test.
